International pharmacovigilance for biotechs brings about a particular set of challenges, especially for small companies, which face the same rigour as large pharma companies.
Judith M. Sills, PharmD
Advertisement
Judith M. Sills, PharmD, is a nonexecutive director and advisor to Arriello—a provider of risk management and compliance services to the Life Sciences industry.
Articles by Judith M. Sills, PharmD
Advertisement
Latest Updated Articles
Navigating International PharmacovigilanceJune 2nd 2021
Advertisement
Advertisement